News

How might US health plans cover efgartigimod for generalized myasthenia gravis? Lessons from the SPEC Database

November 4, 2021 Read Article

Call for papers: 2021 Tufts-CEVR's cost-effectiveness analysis paper of the year award

October 26, 2021 Read Article

10,000th CEA for the CEA Registry

October 19, 2021 Read Article

US Commercial Payer Coverage of Dupilumab Varies Widely

September 24, 2021 Read Article

2020 Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner

July 28, 2021 Read Article

CEVR Appoints HEOR Experts to Scientific Advisory Board

July 26, 2021 Read Article

Unknown unknowns – Uncertainty in Health Technology Assessment: A Case Study of PARP inhibitors for Ovarian Cancer

July 14, 2021 Read Article

Takeaways from Professor Ashish Jha’s assessment of pandemic management by Governor Charlie Baker

July 12, 2021 Read Article

Fulfilling the potential of the National Diabetes Prevention Program

July 1, 2021 Read Article

CEVR Welcomes 2021 Summer Fellows

June 21, 2021 Read Article